Kronos Bio, Inc. Cash and Cash Equivalents
Kronos Bio, Inc. had Cash and Cash Equivalents of $91.58 million as of 2025-03-31, per its 10-Q filed 2025-05-08.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2025-05-08
- 2025-03-31: Cash and Cash Equivalents, at Carrying Value $91.58M.
- 2024-12-31: Cash and Cash Equivalents, at Carrying Value $84.57M.
- 2024-09-30: Cash and Cash Equivalents, at Carrying Value $74.96M.
- 2024-06-30: Cash and Cash Equivalents, at Carrying Value $70.21M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2025-03-31 | $91.58M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $84.57M 10-Q · filed 2025-05-08 |
| 2024-09-30 | $74.96M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $70.21M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $46.20M 10-Q · filed 2025-05-08 |
| 2023-12-31 | $64.33M 10-K · filed 2025-03-18 |
| 2023-09-30 | $57.60M 10-Q · filed 2024-11-13 |
| 2023-06-30 | $44.40M 10-Q · filed 2024-08-08 |
| 2023-03-31 | $61.65M 10-Q · filed 2024-05-09 |
| 2022-12-31 | $75.97M 10-K · filed 2024-03-21 |
| 2022-09-30 | $67.48M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $86.14M 10-Q · filed 2023-08-08 |
| 2022-03-31 | $148.98M 10-Q · filed 2023-05-10 |
| 2021-12-31 | $198.27M 10-K · filed 2023-03-15 |
| 2021-09-30 | $216.99M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $185.66M 10-Q · filed 2022-08-04 |
| 2021-03-31 | $141.45M 10-Q · filed 2022-05-04 |
| 2020-12-31 | $248.01M 10-K · filed 2022-02-24 |
| 2020-09-30 | $156.20M 10-Q · filed 2021-11-09 |
| 2020-06-30 | $37.97M 10-Q · filed 2021-08-12 |
| 2020-03-31 | $28.80M 10-Q · filed 2021-05-11 |
| 2019-12-31 | $32.57M 10-K · filed 2022-02-24 |
| 2019-09-30 | $102.74M 10-Q · filed 2020-11-18 |